Stefani Wolff, EVP and COO at Nurix Therapeutics, Inc. (NRIX), sold 330 shares at $11.75 ($4K) on 2022-05-02, disclosed to the SEC on 2022-05-03.
Open-market sale of $4k NRIX by EVP and COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NRIX | SELL | 2022-11-01 | $5K | — | Filing → |
| NRIX | SELL | 2022-08-02 | $6K | — | Filing → |
| PRNB | SELL | 2020-06-17 | $639K | — | Filing → |